Licensed Combination Products definition

Licensed Combination Products means pharmaceutical compositions comprised of the Compound as a therapeutically active ingredient in combination with other active ingredients and which uses or is developed or manufactured using or in connection with the Supernus Intellectual Property.
Sample 1Sample 2Sample 3
Licensed Combination Products means pharmaceutical combinations and compositions that have been prepared and are in a tablet form containing 50mg of DTG Compound ready for administration to Adult Patients solely for antiretroviral therapy for HIV/AIDS which contain the DTG Compound as an active ingredient in combination with (a) the ABC Compound and/or (b) other active ingredients (subject to the limitation set out in Clause 2.8) and in each case where the resulting combination product has been recommended by the World Health Organisation or the United States Department of Health and Human Services, in each case for supply to and use by Adult Patients.
Sample 1
Licensed Combination Products means any product that is comprised in part of a Licensed Product and in part of one or more other biologically active diagnostic, preventive or therapeutic agents which are not themselves Licensed Products (the "Other Agents"). "Other Agents" excludes diluents and vehicles of Licensed Products.
Sample 1

Examples of Licensed Combination Products in a sentence

  • Subject to the terms and conditions contained in this Agreement, and in consideration of the rights granted by Supernus hereunder, United Therapeutics shall pay Supernus, or an Affiliate of Supernus designated in writing, the following Milestone Payments as pertaining to the development of Licensed Products or Licensed Combination Products for a second indication, contingent upon the occurrence of the corresponding specified contingent Milestone Event detailed below.

  • For the sake of clarity, Sanofi-Aventis shall be entitled to make, have made, use, sell, have sold, develop or have developed Licensed Combination Products in the U.S. Territory after the end of the Exclusivity Term, subject to the last sentence of Section 8.2(c).

  • Save as provided above, we may terminate the Service at any time at our discretion with reasonable notice.

  • Company shall keep, and shall require sublicensees to keep accurate and correct records of Licensed Products, Licensed Combination Products or Licensed Processes or Services made, used or sold under this Agreement, appropriate to determine the amount of royalties due hereunder to University.

  • But this is not entirely true; although the questions of how species is represented and what its nature is are not identical, they might not be independently answered.

  • Company shall use its best efforts, consistent with sound and reasonable business practices and judgment, to effect commercialization of Licensed Products, Licensed Combination Products, Licensed Processes or Services as soon as practicable and to maximize these sales.

  • Subject to the terms of this Agreement, Supernus hereby grants United Therapeutics an exclusive license in the Field under the Supernus Intellectual Property to develop, make, have made, use, offer for sale, sell, have sold and import Licensed Products and Licensed Combination Products in the Territory for the Royalty Term.

  • A license that is exclusive against Third Parties but non-exclusive as to Sanofi-Aventis in the U.S. Territory with the right to grant sublicenses in the U.S. Territory (upon prior written approval of Sanofi-Aventis) under the Patent Rights to make, have made, use (subject to Section 2.6), sell and have sold the Licensed Combination Products in the Field of Use for the remaining term of this Agreement.

  • Quieter PME are defined as having SWLs less than those listed in the XX-XX, and such PME for various construction activities are proposed in Table 4.6 and in accordance with BS 5228: Part I 1997 unless specified.

  • After sales of Licensed Products, Licensed Combination Products, Licensed Processes or Services begins, Company shall provide written quarterly royalty reports within thirty (30) days after each calendar quarter which shall include, but not be limited to: reports of progress on research and development, regulatory approvals, manufacturing, sublicensing, marketing and sales during the preceding three (3) months as well as plans for the coming quarter.


More Definitions of Licensed Combination Products

Licensed Combination Products has the meaning given to such term in the Sublicence;
Sample 1
Licensed Combination Products means pharmaceutical combinations and compositions that have been prepared and are in a tablet form containing 50mg of DTG Compound ready for administration to Adult Patients solely for antiretroviral therapy for HIV/AIDS which contain the DTG Compound as an active ingredient in combination with (a) the ABC Compound and/or (b) other active ingredients (subject to the limitation set out in Clause 2.9) and in each case where the resulting combination product has been recommended by the World Health Organisation for supply to and use by Adult Patients.
Sample 1

Related to Licensed Combination Products

  • Combination Products means any product containing both a pharmaceutically active agent or ingredient which constitutes a Licensed Product and one or more other pharmaceutically active agents or ingredients which do not constitute Licensed Products.

  • Combination Product means any product that comprises a Licensed Compound or Licensed Product sold in conjunction with another active component so as to be a combination product (whether packaged together or in the same therapeutic formulation).

  • Licensed Product means a product, method or service in the Licensed Field of Use, the making, having made, using, importing or selling of which, absent this license, infringes, induces infringement, or contributes to infringement of a Licensed Patent.

  • Licensed Compounds means any EZH2 Compound(s) that is:

  • Licensed Compound means [***].

  • Licensed Products means tangible materials which, in the course of manufacture, use, sale, or importation, would be within the scope of one or more claims of the Licensed Patent Rights that have not been held unpatentable, invalid or unenforceable by an unappealed or unappealable judgment of a court of competent jurisdiction.

  • Collaboration Product means a pharmaceutical product containing or comprising Compound in any dosage form alone, or in combination with, one or more other pharmaceutically active ingredients, and any and all Improvements thereto.

  • Diagnostic Product means any test or assay for diagnosing or detecting a disease, disorder, medical condition, or symptom.

  • complex product means a product which is composed of multiple components which can be replaced permitting disassembly and re-assembly of the product.

  • Competing Product means […***…].

  • Competing Products means any product or service in existence or under development that competes with any product or service of the Company Group about which the Participant obtained Confidential Information or for which the Participant provided advisory services or had sales, origination, marketing, production, distribution, research or development responsibilities in the last twenty-four (24) months of employment with the Company Group.

  • Bundled Product means Product sold together with any other product(s) or service(s) at a single unit price, whether packaged together or separately, and which other product(s) or service(s) have material independent value from Product itself.

  • Hemp product means the same as that term is defined in § 3.2-4112.

  • Licensed Fields of Use means the fields of use identified in Appendix B.

  • Hemp products means all products made from industrial hemp,

  • Marihuana-infused product means a topical formulation, tincture, beverage, edible substance, or similar product containing marihuana and other ingredients and that is intended for human consumption.

  • Roll-on product means any antiperspirant or deodorant that dispenses active ingredients by rolling a wetted ball or wetted cylinder on the affected area.

  • Biosimilar Product means, with respect to a Licensed Product in any country, any biosimilar product sold by a Third Party not authorized by or on behalf of Celgene, its Affiliates or Sublicensees, (a) that is a biosimilar biological product, as defined in 21 USC 379j-51 (or any successor or replacement thereof), a similar biological medicinal product, as defined in Annex I to Directive 2001/83/EC (or any successor or replacement thereof), or any similar biosimilar or generic product under the Laws of any country or jurisdiction, or (b) regarding which Regulatory Approval is obtained by referencing Regulatory Data of such Licensed Product.

  • Therapeutically equivalent drug products means drug products that contain the same active

  • Generic Product means any pharmaceutical product that (i) is sold by a Third Party that is not an Affiliate or licensee of Buyer and (ii) (a) contains the same active pharmaceutical ingredient as the Product or (b) is categorized by the applicable Governmental Entity in a country to be therapeutically equivalent to, or interchangeable with, the Product, such that the pharmaceutical product may be substituted for the Product at the point of dispensing without any intervention by the prescribing physician in such country.

  • Licensed producer means a person or entity licensed to produce medical cannabis.

  • Spray buff product means a product designed to restore a worn floor finish in conjunction with a floor buffing machine and special pad.

  • Tobacco product means any substance containing tobacco leaf, including but not limited to, cigarettes, cigars, pipe tobacco, hookah tobacco, snuff, chewing tobacco, dipping tobacco, bidis, blunts, clove cigarettes, or any other preparation of tobacco; and any product or formulation of matter containing biologically active amounts of nicotine that is manufactured, sold, offered for sale, or otherwise distributed with the expectation that the product or matter will be introduced into the human body by inhalation; but does not include any cessation product specifically approved by the U.S. Food and Drug Administration for use in treating nicotine or tobacco dependence.

  • Licensed Field means all fields of use.

  • Reference biological product means the single biological product licensed pursuant to 42 U.S.C.

  • Commercialized shall have corresponding meanings.